When military revenue jumps from under half to nearly two-thirds of total sales in a single quarter, and the company swings from a loss to a profit, that is not noise. That is an operational shift, and this aerospace forger just delivered exactly that.

We’ll help you decide whether the growing defense backlog and the discount to aerospace peers make this the value setup worth acting on right now.

See Why (Sponsored)

The Trump Administration is Loading Up on Stocks.

15% Stake in MP Materials... Up 216% in 4 Months.

10% Stake in Lithium Americas... A triple in 3 weeks.

10% Stake in Trilogy Metals... Up 388% in 8 days!

Electronic Technology

The Aerospace Forger That Quietly Flipped From Loss to Profit This Quarter

SIFCO Industries Inc. (NYSE: SIF) just posted Q1 fiscal 2026 results, and the headline is a clean swing from a net loss to profitable.

Revenue climbed almost 15% on two things working together: higher throughput moving more product through the factory, and lower fixed costs doing less damage on the way out.

What is driving the volume is the commercial aerospace recovery.

Boeing and Airbus are grinding through production backlogs, and SIFCO makes components that cannot be skipped in that supply chain, so the demand signal is tied to a real ramp rather than speculation.

The Throughput Story Is What You Actually Want to See

Profitability from cutting costs disappears quickly.

Profitability from moving more volume through the same facility is stickier.

Higher throughput with lower fixed cost dilution is what drove the result, and that combination tends to compound rather than fade.

Commercial Aerospace Demand Is Still in Early Recovery

Boeing and Airbus have years of backlog to work through, so the demand feeding into SIFCO’s order book is still building rather than peaking.

Order visibility for suppliers at this stage of the cycle tends to improve quarter by quarter.

Energy Minerals

This Rare Earth Company Had Three Operational Milestones in One Week

American Resources Corporation (NASDAQ: AREC) dropped three pieces of news in one week.

  • ReElement filed its eighth next-generation patent for lithium brine separation and purification.

  • The Electrified Materials subsidiary expanded capacity at its Indiana facility with a State of Indiana recycling grant behind it.

  • The company was presenting at the UNC Clean Tech Summit and a Washington DC financing roundtable on critical mineral supply chains.

Eight patent filings on a single refining platform in a short period tell you the IP is being built out aggressively before larger players arrive. That is exactly what you want to see from a company trying to own the domestic critical minerals refining layer.

Eight Patent Applications on One Platform Is Not a Coincidence

Rapid IP filing around a single technology signals a company building a moat before the market gets crowded.

ReElement is doing that in rare earth separation and lithium refining, two areas where domestic capacity is urgently needed.

The Indiana Grant Signals External Validation

State grants do not go to speculative operations. Indiana backing the facility expansion tells you someone with something to lose looked at the technology and decided it was worth supporting.

Now Open (Sponsored)

While President Trump's official salary is $400,000 per year... his tax returns reveal he's been collecting up to $250,000 PER MONTH from one hidden source.

Until recently, most Americans couldn't touch the type of investment that makes up this investment.

But thanks to Executive Order 14330, that just changed. If you love investing in disruptive new companies...

Discover how to invest in the fund Trump uses to collect this income 

Finance

This Solana Treasury Company Just Published a Research Report on AI Agents and Moved 12%

DeFi Development Corp. (NASDAQ: DFDV) published a research report on March 10 arguing that autonomous AI agents will create structural demand for Solana as the settlement layer for agentic activity, and the stock moved over 12% on the day.

The logic is simple: AI agents need to pay for compute and services on a blockchain, and Solana’s speed and low costs make it the natural fit.

DFDV holds Solana as its primary treasury asset and earns staking income from it, so if the AI agent thesis develops, the treasury appreciates and the income compounds.

Full-year 2025 results drop soon, your next concrete look at how the strategy has actually been performing.

The AI Angle Is New, and It Is Moving the Narrative

Connecting Solana demand to autonomous AI agents is a newer argument than the standard crypto treasury story.

Sitting at the intersection of crypto infrastructure and AI puts DFDV in a different conversation than most blockchain treasury names.

March 30 Earnings Drop Is the Near-Term Catalyst to Watch

Full-year results and an outlook from management are coming at the end of the month.

That is your chance to see whether the staking income and treasury performance match the strategic positioning the company has been building all quarter.

Actionable Picks This Week

Ovid Therapeutics Inc. (NASDAQ: OVID) is up 448% over the past year, and the catalyst calendar for the next few months is why the strong buy consensus is still standing.

OV329 just posted clean safety data at the 7mg dose with zero adverse events, and two new epilepsy indications were added to the program in the same week.

A $60 million private placement backed by institutional names, including Point72 and Balyasny, closed alongside Australian Phase 1 clearance for a second program, and Phase 2 for OV329 kicks off in Q2.

Cash runway extends to 2029 if warrants are exercised, so you are not watching a dilution clock while the pipeline delivers.

Seagate Technology Holdings PLC (NASDAQ: STX) has hyperscalers booked on hard disk drive capacity well into 2027, meaning the revenue question is not whether demand is there but whether the company can keep shipping into it.

The stock has tripled over the past year while earnings growth kept pace, so you are not walking into a stretched multiple on a business whose revenue is largely already sold.

Pricing power in a market where capacity is pre-sold keeps the margin story intact, and AI storage demand tied to model training keeps extending the runway beyond the current booking horizon.

The business is compounding steadily rather than spiking, which is the kind of setup that holds up better when the broader market gets volatile.

For a hardware name with contracted demand and a clean earnings trajectory, the risk-reward here is one of the more readable setups in the sector right now.

Western Digital Corporation (NASDAQ: WDC) confirmed its full 2026 hard disk drive capacity is already sold out to hyperscalers, which removes a lot of the forecasting uncertainty that usually comes with hardware names.

The company reinstated the dividend and raised it in the same announcement, which is not something management does when they are uncertain about cash flow.

The earnings target came in well above where consensus was sitting, and contracted capacity for the full year means each quarterly print is more confirmation than surprise.

Flash storage adds a second leg that broadens the AI infrastructure exposure beyond just hard drives.

Between sold-out capacity, a raised dividend, and an earnings target moving in the right direction, the story is making a lot of its own arguments right now.

Get Access (Sponsored)

From thousands of stocks, only five stood out as having the best chance to gain +100% or more in the months ahead.

A newly released 5 Stocks Set to Double special report reveals all five tickers — free for a limited time.

While future results can’t be guaranteed, previous editions of this report delivered gains of +175%, +498%, and even +673%¹.

The newest picks could follow a similar path.

This free opportunity expires at MIDNIGHT TONIGHT.

Get the free report here

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Fast Movers to Watch

  • Erasca Inc. (NASDAQ: ERAS) is up over 900% in the past year, targeting RAS and MAPK pathway cancers with multiple clinical readouts expected in 2026 and a strong buy rating still intact.

    Analysts are upgrading into the data calendar rather than chasing the price, which tells you the institutional view is that the pipeline is still ahead of the tape. Get the readout dates marked before the data arrives.

  • Shattuck Labs Inc. (NASDAQ: STTK) is up over 420% in the past year in immuno-oncology, with a strong buy consensus that has not moved despite the run.

    The 2026 clinical calendar is active across multiple programs, and the momentum has been building on actual data updates rather than sentiment. Worth having on your radar before the next readout drops.

  • Tango Therapeutics Inc. (NASDAQ: TNGX) is up over 1,000% in the past year, targeting synthetic lethality in precision oncology with a strong buy consensus and active 2026 data expected.

    The focus on cancers with specific genetic mutations gives it a cleaner clinical path than broad oncology programs, and positioning before the data matters more than reacting after it lands.

Trivia: What percentage of U.S. households are estimated to be millionaires (net worth ≥ $1M), according to recent Federal Reserve data?

Login or Subscribe to participate

Everything Else

That's our coverage for today; thanks for reading! Reply to this email with feedback or any value names you'd like us to dig into.

Best Regards,
—Noah Zelvis
Undervalued Edge

Keep Reading